Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Operating Margin Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Operating Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 327.00
Mar 31, 2026 235.00
Dec 31, 2025 560.00
Sep 30, 2025 678.00
Jun 30, 2025 1,014.00
Mar 31, 2025 595.00
Dec 31, 2024 1,008.00
Sep 30, 2024 675.00
Jun 30, 2024 644.00
Mar 31, 2024 572.00
Dec 31, 2023 525.00
Sep 30, 2023 590.00
Jun 30, 2023 743.00
Mar 31, 2023 576.00
Dec 31, 2022 450.00
Sep 30, 2022 534.00
Jun 30, 2022 744.00
Mar 31, 2022 531.00
Dec 31, 2021 536.00
Sep 30, 2021 -588.00